AMGN Stock: Price, Earnings History and SEC Filings
Amgen Inc. (AMGN) last traded at $466.01, up 1.15% on the latest session and up 10.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $6.29 against an analyst estimate of $5.60, a beat of 12.3%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AMGN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $6.29 | $5.60 | +12.32% |
| Mar 2026 | Apr 30, 2026 | $5.15 | $4.73 | +8.88% |
| Dec 2025 | Feb 3, 2026 | $5.29 | $4.76 | +11.13% |
| Sep 2025 | Nov 4, 2025 | $5.64 | $5.00 | +12.80% |
AMGN beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How AMGN reacts to earnings
Across its last 8 earnings releases, AMGN moved 4.9% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-04 | After close | +4.57% |
| 2026-04-30 | After close | -4.75% |
| 2026-02-03 | After close | +8.15% |
| 2025-11-04 | After close | +7.81% |
| 2025-08-05 | After close | -5.14% |
| 2025-05-01 | After close | -0.90% |
| 2025-02-04 | After close | +6.50% |
| 2024-10-30 | After close | +1.46% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
Latest SEC filings for AMGN
- 8-K · Oct 27, 2026Officer or director change
- 10-Q · Aug 5, 2026
- 8-K · Aug 4, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 31, 2026
- 8-K · May 20, 2026Shareholder vote
- 8-K · May 19, 2026Officer or director change
- 10-Q · May 1, 2026
- 8-K · Apr 30, 2026Results of operations, Financial statements and exhibits
- 8-K · Apr 22, 2026Officer or director change, Financial statements and exhibits
- DEF 14A · Apr 7, 2026
Insider filing activity
AMGN insiders filed 7 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
AMGN news
- Dow Jones Futures Loom After Market Sell-Off; How Midterm Elections May Swing StocksNov 1, 2026 · finance.yahoo.com
- Looking For Growth, Income, and Stability? This Stock Could Offer All 3Oct 31, 2026 · fool.com
- Amgen (AMGN) Gets A Fresh Look As Phase 3 Wins Meet A Pricey NarrativeOct 31, 2026 · finance.yahoo.com
- New CFO Appointment Could Be A Big Moment For Mattel (MAT)Oct 31, 2026 · finance.yahoo.com
- Big Homes, Big LoansOct 30, 2026 · finance.yahoo.com
- Stocks Fall Sharply on Intel and Amazon Sell-offs and Crypto HeistOct 30, 2026 · barchart.com
- Regeneron Soars 12% on Dupixent-Fueled Q3 Beat: “One of Our Strongest Years Ever”Oct 30, 2026 · tikr.com
- AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling StockOct 30, 2026 · finance.yahoo.com
About Amgen Inc.
Amgen Inc. (AMGN) is a US-listed public company on Nasdaq. The SEC classifies its business as Biological Products (no Diagnostic Substances). It is incorporated in DE. Its fiscal year ends in December.